drugset / Trial / NCT01605201
Tissue Engineered Nasal Cartilage for Regeneration of Articular Cartilage
Phase 1
Completed
18 enrolled
University Hospital, Basel, Switzerland
Deutsche Arthrose-Hilfe · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the safety and feasibility of implanting an engineered cartilage graft obtained by culturing expanded autologous nasal chondrocytes within a collagen type I/III membrane into the cartilage defect on the femoral condyle and/or trochlea of the knee after a traumatic injury.
Timeline
- Start
- 2012-08-29
- Primary completion
- 2018-08-15
- Completion
- 2018-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tissue engineered cartilage graft | Cell therapy | — | — |